Brian Wainger is Assistant Professor of Neurology and Anesthesiology at Harvard Medical School and a physician scientist at Massachusetts General Hospital engaged in clinical practice, translational science, and clinical trials spanning diseases of the motor and sensory nervous systems. He received his undergraduate degree in molecular biology from Princeton University and MD/PhD degrees from Columbia University. He completed medical residency in the Partners Neurology Program, clinical fellowship in Interventional Pain Medicine at Massachusetts General Hospital, research fellowship at Boston Children’s Hospital, and Masters Program in Clinical and Translational Investigation at Harvard Medical School. He has recently led a successful 12-site Phase 2 clinical trial of ezogabine treatment and motor neuron neurophysiology in ALS participants. He is a Principal Investigator in the Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital, where his lab research focuses on modeling motor and sensory neuron diseases using stem cell technology, and Principal Faculty at the Harvard Stem Cell Institute, Associate Member of the Broad Institute, and member of the Harvard Program in Neurobiology. He is the recipient of a K08 Career Development award and NIH New Innovator award and is a New York Stem Cell Foundation – Robertson Investigator and MGH Trustees Endowed Scholar in Anesthesia and Neuroscience.
For the NeuroNEXT Network, Dr. Wainger is a study design lead for the Clinical Coordinating Center.